| Literature DB >> 28490253 |
Abstract
Over the past 10 years, numerous public debates on new and emerging science and technologies have taken place in the United Kingdom. In this article, we characterise the discourses emerging from these debates and compare them to the discourses in analogous expert scientific and policy reports. We find that while the public is broadly supportive of new scientific developments, they see the risks and social and ethical issues associated with them as unpredictable but inherent parts of the developments. In contrast, the scientific experts and policymakers see risks and social and ethical issues as manageable and quantifiable with more research and knowledge. We argue that these differences amount to two different sociotechnical imaginaries or views of science and how it shapes our world - an elite imaginary of 'science to the rescue' shared by scientists and policymakers and public counter-imaginary of 'contingent progress'. We argue that these two imaginaries indicate that, but also help explain why, public dialogue has had limited impact on public policy.Entities:
Keywords: governance; public dialogue; public discourse; public engagement
Year: 2017 PMID: 28490253 PMCID: PMC6055116 DOI: 10.1177/0963662517706452
Source DB: PubMed Journal: Public Underst Sci ISSN: 0963-6625
Summary of analysis of public dialogue reports.
| Class | Illustrative statement | Ten most significant words | Documents associated |
|---|---|---|---|
| Class A1 (15.1%): Drugs – Cure or cause, treating medical or social problems? | ‘I know that drugs like heroin need to be illegal because of the harm they cause – especially for vulnerable young people. But I suppose we could say the same about other recreational drugs like alcohol or nicotine, which can also be addictive. And while prescription drugs can help people with mental health problems, where do we draw the line with social problems? Should people be allowed to take drugs that help them do well in education, for instance?’ | drug | Drugsfutures (2006) |
| Class A2 (25.5%): ‘Reaching potential whilst minimising risk’ | ‘These technologies show a lot of promise to develop medical treatments in the future. But there are also risks (some unknown) and the private companies involved will be driven by the need to make a profit. We need to think about how we govern and regulate this tension’. | application | BBSRC Synthetic Biology (2009) |
| Class A3: Precautionary in Principle | ‘We need to know a lot more about these new technologies and to discuss them further before we can make decisions and policy about them. We need independent advice about whether they will work and what the costs and side effects will be’. | climate | Geoengineering (2010) |
| Class A4 (17.6%): The slippery slope to challenging our way of life | ‘These technologies might bring some economic benefits and cheap food, but I don’t think we have the right to do this to the natural world. In the long term, I’m worried about whether there are safe, their effects on the environment and where this will lead’. | industrial | Industrial Biotechnology (2006) |
| Class A5 (17.8%): Where do we draw the moral line when we mess with humans? | ‘The things that scientists can do with these technologies is not natural and I am not sure we have the moral right to do this. I can see that they might help some people, but I think I can only accept it if it will help humans with life-threatening conditions’. | animal | Animals Containing Human Material (2010) |
BBSRC: Biotechnology and Biological Sciences Research Council; GM: Genetically Modified.
Summary of analysis of expert reports.
| Class | Illustrative statement | Ten most significant words | Documents associated |
|---|---|---|---|
| Class B1 (17.16%) ‘Addressing public concerns on social and ethical issues’ | ‘Developments in this area bring with them a number of social and ethical issues which were identified by the public in our discussions and which must be addressed if we are to take full advantage of the opportunities offered by this technology’. | public | Geoengineering (2009) |
| Class B2 (21.44%): ‘GM reassurance’ | ‘GM crops will bring huge benefits to the UK. Most of the risks associated with them are either not based on the scientific evidence, are reversible or can be avoided. In fact, many of the possible problems are no worse than the problems associated with current practices anyway’. | crop | GM Science Review (2003) |
| Class B3 (24.60%) ‘Brain Science’ | ‘People already use psychoactive drugs – legally or illegal. New brain drugs like cognition enhancers will help treat mental illnesses and things like Alzheimer’s disease but the members of the public we talked to were concerned that they could be abused and lead to new problems’. | drug | Brain Science (2008) |
| Class B4 (17.61%) ‘The biomedical science bit’ | ‘Research in which human pluripotent stem cells are introduced into animal embryos will clarify the potential of such introduced cells to contribute to addressing questions around the advancement of knowledge into cancer and Parkinson’s’. | cell | Hybrids and Chimera (2007) |
| Class B5 (20.1%), ‘Growth, economy and planet’ | ‘Investing in the right aspects of these technologies will allow UK to be competitive in the global market place, grow our economy and help us solve some serious problems ahead, like identifying new sources of energy’. | chemical | Nanosciences (2004) |
GM: Genetically Modified; IB: Industrial Biotechnology.
Summary of analysis of policy reports.
| Class | Illustrative statement | Ten most significant words | Documents associated |
|---|---|---|---|
| Class C1 (16.72%) ‘Safety and choice so that we can get huge benefits from GM’ | ‘GM crops could offer real benefits to consumers and farmers in the future and our comprehensive research has found no reason to think they pose any risks to human health, nor are any less safe than conventional crops. We do need to monitor this for unforeseen problems though and consider each on a case-by-case basis but much will depend on whether consumers choose gm foods and on the ability of the regulatory system to continue to manage any risks effectively’. | gm | Government’s response to GM Nation Debate |
| Class C2 (29.15%): Regulation of human embryology research | ‘The government should open the door to research using human animal chimera or hybrid embryos, as it is likely to bring significant health benefits in the future. There is little opposition, besides that based on opposition to research on human embryos in general. Legal advice is needed to consider the humanness of embryos, so that it is clear whether such matters should be regulated by HFEA or another agency, and the regulation needs to provide a clear framework within which research can take place’. | embryo | UK government’s response to the Joint Committee Report of
the Human Tissues and Embryos Draft Bill (2007) |
| Class C3 (29.08%): Anticipating and managing risks and adapting regulation, to ensure UK maintains an international lead | ‘The government will ensure a coordinated approach to developing this technology, which will be reviewed at 5 and 10 year intervals. This approach will bring together a wide range of stakeholders and the public, so that we can anticipate, understand and manage potential risks, address public concerns and ensure the responsible development of these fields while maintaining our international competitiveness’. | commission | Government responses to reports on nanoscience, geoengineering and regenerative medicine. |
| Class C4 (25.05%): Supporting technology transfer | ‘The government recognises the importance of the UK’s science base in providing the new ideas and innovations for translation into applications. The government will provide funding for such research over the next decade and develop a strategy to support businesses in exploiting this’. | ib | UK government’s responses to reports on industrial biotechnology, the UK stem cell initiative, nanosciences and synthetic biology. |
GM: Genetically Modified; HFEA: Human Fertilisation and Embryology Authority; IB: Industrial Biotechnology; BBSRC: Biotechnology and Biological Sciences Research Council.
Comparison of key features of public, expert and policy discourses.
| Public | Expert | Policy | |
|---|---|---|---|
| Sense of progress | Positive sense of contingent progress | Positive enthusiasm | Positive enthusiasm – benefits assumed not specified |
| Focus | Focus on people; nature important | Focus on science and uses technical language | Focus on economies and markets, science and citizens |
| View of social and ethical issues | Social and ethical issues inherent parts of science and technologies | Social and ethical issues seen as epiphenomena | Social and ethical issues seen as epiphenomena |
| Risk and certainty | Technologies seen as uncertain, unpredictable and contingent | Technologies seen as predictable and manageable with enough research | Unpredictability and contingency of technologies acknowledged, but focus on management |
| Role of industry | Industry seen as a diverting force | Industry seen as a beneficiary of science | Industry seen as a funder and beneficiary of science |
| Role of government | Role of government in managing balance and regulating role of industry | Role of government described but not prescribed | Role of government in funding basic research and enabling private sector |